Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children

British Journal of Haematology

Volumn 161, Issue 3, 2013, Pages 402-405

  Estepp, Jeremie H ^a   Smeltzer, Matthew P ^a   Wang, Winfred C ^a   Hoehn, Mary E ^b   Hankins, Jane S ^a   Aygun, Banu ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Foetal haemoglobin; Hydroxycarbamide; Sickle cell anaemia; Sickle cell retinopathy

Indexed keywords

HEMOGLOBIN F; HYDROXYUREA;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTECTION; RETINOPATHY; RETROSPECTIVE STUDY; SCHOOL CHILD; SICKLE CELL ANEMIA; SICKLE CELL RETINOPATHY; TREATMENT DURATION;

ADOLESCENT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; CHILD; DRUG EVALUATION; FEMALE; FETAL HEMOGLOBIN; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION; HUMANS; HYDROXYUREA; INCIDENCE; MALE; RETINAL DISEASES; RETROSPECTIVE STUDIES; RISK; VITREORETINOPATHY, PROLIFERATIVE;

EID: 84876175270     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12238     Document Type: Article

References (8)

1. Friberg, T.R., Young, C.M. & Milner, P.F. (1986) Incidence of ocular abnormalities in patients with sickle hemoglobinopathies. Annals of Ophthalmology, 18, 150-153.
2. Gill, H.S. & Lam, W.-C. (2008) A screening strategy for the detection of sickle cell retinopathy in pediatric patients. Canadian Journal of Opthalmology, 43, 188-191.
3. Goldberg, M.F. (1971) Classification and pathogenesis of proliferative sickle retinopathy. American Journal of Ophthalmology, 71, 649-655.
4. Heeney, M.M. & Ware, R.E. (2008) Hydroxyurea for children with sickle cell disease. Pediatric clinics of North America, 55, 483-501.
5. Moriarty, B.J., Acheson, R.W., Condon, P.I. & Serjeant, G.R. (1988) Patterns of visual loss in untreated sickle cell retinopathy. Eye, 2, 330-335.
6. Rosenberg, J.B. & Hutcheson, K.A. (2011) Pediatric sickle cell retinopathy: correlation with clinical factors. Journal of American Association for Pediatric Ophthalmology and Strabismus, 15, 49-53.
7. Wang, W.C., Ware, R.E., Miller, S.T., Iyer, R.V., Casella, J.F., Minniti, C.P., Rana, S., Thornburg, C., Rogers, Z.R., Kalpatthi, R.V., Barredo, J.C., Brown, R.C., Sarnaik, S.A., Howard, T.H., Wynn, L.W., Kutlar, A., Armstrong, F.D., Files, B.A., Goldsmith, J.C., Waclawiw, M.A., Huang, X. & Thompson, B.W. (2011) Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). The Lancet, 377, 1663-1672.
8. Ware, R.E. (2010) How I use hydroxyurea to treat young patients with sickle cell anemia. Blood, 115, 5300-5311.